编程细胞死亡在骨髓瘤中的作用:从病变发生到治疗
Suqing Liu1,2, Chengtao Liu3, Yian Wang2
1Department of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Cancer medicine
|May 27, 2024
概括
骨髓瘤 (OS) 是一种影响青少年的骨癌. 针对编程细胞死亡 (PCD) 和相关途径为这种攻击性癌症提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 骨髓瘤 (OS) 是一种主要影响青少年 (14-19岁) 的骨癌.
- 这种OS非常具有攻击性,具有显著的转移风险,特别是在肺部.
- 编程细胞死亡 (PCD) 越来越多地被认为是其在OS发展和进展中的关键作用.
研究的目的:
- 审查各种PCD形式在骨髓瘤中的作用.
- 探索关键信号通路在OS中调节PCD中的参与.
- 突出在OS治疗中针对PCD和相关途径的治疗潜力.
主要方法:
- 在骨髓瘤中PCD实验证据的文献综述.
- 对影响OS细胞PCD的信号通路的分析.
- 综合关于针对PCD的治疗策略的信息.
主要成果:
- 多种PCD形式,包括亡,铁亡,自亡,亡和热亡,显著影响OS的进展.
- 特定的信号通路 (STAT3/c-Myc,JNK,PI3K/AKT/mTOR,WNT/β-catenin,Rhoa) 调节骨髓瘤细胞中的PCD.
- 这些途径为新的治疗干预提供了潜在的目标.
结论:
- 编程细胞死亡 (PCD) 是骨髓瘤发育和进展的关键因素.
- 针对特定的PCD机制和相关的信号通路,为骨髓瘤提供了一个有前途的治疗途径.
- 对这些途径的进一步研究可能会导致对这种侵袭性骨癌的更有效的治疗方法.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


